Roivant Sciences' Corporate Minority Round

Roivant Sciences raised a round of funding on August 09, 2017.

Roivant Sciences focuses on developing and commercializing novel therapies through wholly- or majority-owned subsidiary companies including, Axovant, Myovant, Dermavant, Enzyvant, and Urovant.…

Articles about Roivant Sciences' Corporate Minority Round: